Pham TT, Hungnes IN, Rivas C, Cleaver J, Firth G, Blower PJ, Sosabowski J, Cook GJR, Livieratos L, Young JD, Pringle PG and T. M (2024). Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of 99mTc and 188Re Theranostic Agents for Prostate Cancer. Society of Nuclear Medicine  Journal of Nuclear Medicine  vol. 65, (7)  

Ree SM, Greenwood H, Young JD, Roberts R, Livens FR, Heath SL and Sosabowski JK (2024). Selection of radionuclide(s) for targeted alpha therapy based on their nuclear decay properties. Wolters Kluwer  Nuclear Medicine Communications  vol. 45, (6) 465-473.  

Han S, Wang JT-W, Yavuz E, Zam A, Rouatbi N, Utami RN, Liam-Or R, Griffiths A, Dickson W, Sosabowski J and Al-Jamal KT (2023). Spatiotemporal tracking of gold nanorods after intranasal administration for brain targeting. Elsevier  Journal of Controlled Release  vol. 357, 606-619.  

Pistorius K, Ly L, Souza PR, Gomez EA, Koenis DS, Rodriguez AR, Foster J, Sosabowski J, Hopkinson M, Rajeeve V, Spur BW, Pitsillides A, Pitzalis C and Dalli J (2022). MCTR3 reprograms arthritic monocytes to upregulate Arginase-1 and exert pro-resolving and tissue-protective functions in experimental arthritis. Elsevier  EBioMedicine  vol. 79,  

Dexter K, Foster J, Sosabowski J and Petrik M (2022). Preclinical PET and SPECT Instrumentation. Nuclear Medicine and Molecular Imaging  Elsevier   

Dexter K, Foster J, Petrik M and Sosabowski J (2022). Preclinical PET and SPECT imaging. Nuclear Medicine and Molecular Imaging  Elsevier   

Borràs J, Foster J, Kashani R, Meléndez-Alafort L, Sosabowski J, Suades J and Barnadas-Rodríguez R (2021). New Bioconjugated Technetium and Rhenium Folates Synthesized by Transmetallation Reaction with Zinc Derivatives. MDPI  Molecules  vol. 26, (8)  

Borràs J, Lecina J, Foster J, Kashani R, Melendez-Alafort L, Sosabowski J and Suades J (2021). Bioconjugated technetium carbonyls by transmetalation reaction with zinc derivatives. Elsevier  Bioorganic & Medicinal Chemistry Letters  vol. 37,  

Dexter K, BROWN N, Foster J, Kashani R, CHUPIN J, Cleaver J, Cutmore L, Marshall J and Sosabowski J (2020). Simultaneous dual isotope PET-SPECT/CT imaging of pancreatic cancer. 

Demircioglu F, Wang J, Candido J, Costa ASH, Casado P, de Luxan Delgado B, Reynolds LE, Gomez-Escudero J, Newport E, Rajeeve V, Baker A-M, Roy-Luzarraga M, Graham TA, Foster J, Wang Y, Campbell JJ, Singh R, Zhang P, Schall TJ, Balkwill FR, Sosabowski J, Cutillas PR, Frezza C, Sancho P and Hodivala-Dilke K (2020). Cancer associated fibroblast FAK regulates malignant cell metabolism. Nature Research (part of Springer Nature)  Nature Communications  vol. 11, (1) 1290-1290.  

Wang JT-W, Hodgins NO, Al-Jamal WT, Maher J, Sosabowski JK and Al-Jamal KT (2020). Organ Biodistribution of Radiolabelled δγ T Cells Following Liposomal Alendronate Administration in Different Mice Tumour Models. Ivyspring International Publisher  Nanotheranostics  vol. 4, (2) 71-82.  

Kee CW, Tack O, Guibbal F, Wilson TC, Isenegger PG, Imiołek M, Verhoog S, Tilby M, Boscutti G, Ashworth S, Chupin J, Kashani R, Poh AWJ, Sosabowski JK, Macholl S, Plisson C, Cornelissen B, Willis MC, Passchier J, Davis BG and Gouverneur V (2020). 18F-Trifluoromethanesulfinate Enables Direct C–H 18F-Trifluoromethylation of Native Aromatic Residues in Peptides. American Chemical Society  Journal of the American Chemical Society  vol. 142, (3) 1180-1185.  

Wang JT-W, Klippstein R, Martincic M, Pach E, Feldman R, Šefl M, Michel Y, Asker D, Sosabowski JK, Kalbac M, Da Ros T, Ménard-Moyon C, Bianco A, Kyriakou I, Emfietzoglou D, Saccavini J-C, Ballesteros B, Al-Jamal KT and Tobias G (2019). Neutron Activated 153Sm Sealed in Carbon Nanocapsules for in Vivo Imaging and Tumor Radiotherapy. American Chemical Society (ACS)  ACS Nano  vol. 14, (1) 129-141.  

Stella Man YK, Foster J, Carapuça E, Davies JA, Parker AL, Sosabowski J and Halldén G (2019). Systemic delivery and SPECT/CT in vivo imaging of 125I-labelled oncolytic adenoviral mutants in models of pancreatic cancer. Springer Nature  Scientific Reports  vol. 9, (1)  

Crnogorac-Jurcevic T, Radon T, Shah S, Weeks M, Foster J, Sosabowski J and Dumartin L (2019). AGR2, a unique tumor-associated antigen, is a promising candidate for antibody targeting. Impact Journals  Oncotarget   

Klingler M, Decristoforo C, Rangger C, Summer D, Foster J, Sosabowski JK and von Guggenberg E (2019). Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum. Ivyspring International Publisher  Theranostics  vol. 9, (16) 4595-4596.  

Martinez O, Sosabowski J, Maher J and Papa S (2019). New Developments in Imaging Cell-Based Therapy. Society of Nuclear Medicine  Journal of Nuclear Medicine  vol. 60, (6) 730-735.  

Zhai C, He S, Ye Y, Rangger C, Kaeopookum P, Summer D, Haas H, Kremser L, Lindner H, Foster J, Sosabowski J and Decristoforo C (2019). Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89. MDPI  Biomolecules  vol. 9, (3)  

Faruqu FN, Wang JT-W, Xu L, McNickle L, Chong EM-Y, Walters A, Gurney M, Clayton A, Smyth LA, Hider R, Sosabowski J and Al-Jamal KT (2019). Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal Approach. Ivyspring International Publisher  Theranostics  vol. 9, (6) 1666-1682.  

Klingler M, Summer D, Rangger C, Haubner R, Foster J, Sosabowski J, Decristoforo C, Virgolini I and von Guggenberg E (2018). DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use. Society of Nuclear Medicine  Journal of Nuclear Medicine  vol. 60, (7) 1010-1016.  

Deshayes E, Ladjohounlou R, Le Fur P, Pichard A, Lozza C, Boudousq V, Sevestre S, Jarlier M, Kashani R, Koch J, Sosabowski J, Foster J, Chouin N, Bruchertseifer F, Morgenstern A, Kotzki P-O, Navarro-Teulon I and Pouget J-P (2018). Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer. Society of Nuclear Medicine  Journal of Nuclear Medicine  vol. 59, (8) 1234-1242.  

Klingler M, Decristoforo C, Rangger C, Summer D, Foster J, Sosabowski JK and von Guggenberg E (2018). Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting. Theranostics  vol. 8, (11) 2896-2908.  

Emami-Shahri N, Foster J, Kashani R, Gazinska P, Cook C, Sosabowski J, Maher J and Papa S (2018). Clinically compliant spatial and temporal imaging of chimeric antigen receptor T-cells. Nature Publishing Group  Nature Communications  vol. 9, (1) 1081-1081.  

Costa PM, Wang JT-W, Morfin J-F, Khanum T, To W, Sosabowski J, Tóth E and Al-Jamal KT (2018). Functionalised Carbon Nanotubes Enhance Brain Delivery of Amyloid-Targeting Pittsburgh Compound B (PiB)-Derived Ligands. Ivyspring International Publisher  Nanotheranostics  vol. 2, (2) 168-183.  

Tremoleda JL, Macholl S and Sosabowski JK (2018). Anesthesia and Monitoring of Animals During MRI Studies. Preclinical MRI  Springer Nature   

Rudran B, Reader C, Foster J, Hodivala-Dilke K, Sosabowski J and Marshall J (2018). 12 Blockade of integrin alpha-v-beta-6 (αvβ6) reduces the invasive potential of NSCLC. Elsevier  Lung Cancer  vol. 115, s5-s6.  

Hodgins NO, Al-Jamal WT, Wang JT-W, Klippstein R, Costa PM, Sosabowski JK, Marshall JF, Maher J and Al-Jamal KT (2017). Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy. Elsevier  Journal of Controlled Release  vol. 256, 141-152.  

Macholl S, Finucane CM, Hesterman J, Mather SJ, Pauplis R, Scully D, Sosabowski JK and Jouannot E (2017). High-throughput high-volume nuclear imaging for preclinical in vivo compound screening§. Springer Open  EJNMMI Res  vol. 7, (1) 33-33.  

Dubey RD, Klippstein R, Wang JT-W, Hodgins N, Mei K-C, Sosabowski J, Hider RC, Abbate V, Gupta PN and Al-Jamal KT (2017). Novel Hyaluronic Acid Conjugates for Dual Nuclear Imaging and Therapy in CD44-Expressing Tumors in Mice In Vivo. Ivyspring International Publisher  Nanotheranostics  vol. 1, (1) 59-79.  

Rudran B, Desai A, Luzarraga M, Hodivala-Dilke K, Foster J, Sosabowski J and Marshall J (2017). 6: Development of non-invasive imaging of integrin alpha-v-beta-6 (αvβ6)-positive lung cancers in advance of testing αvβ6-targeted therapies. Elsevier  Lung Cancer  vol. 103,  

Mohamed Suffian IFB, Wang JT-W, Hodgins NO, Klippstein R, Garcia-Maya M, Brown P, Nishimura Y, Heidari H, Bals S, Sosabowski JK, Ogino C, Kondo A and Al-Jamal KT (2016). Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo. Elsevier  Biomaterials  vol. 120, 126-138.  

Denis-Bacelar AM, Cronin SE, Da Pieve C, Paul RL, Eccles SA, Spinks TJ, Box C, Hall A, Sosabowski JK, Kramer-Marek G and Flux GD (2016). Pre-clinical quantitative imaging and mouse-specific dosimetry for 111In-labelled radiotracers. Springer Nature  EJNMMI Research  vol. 6, (1)  

Al-Jamal KT, Bai J, Wang JT-W, Protti A, Southern P, Bogart L, Heidari H, Li X, Cakebread A, Asker D, Al-Jamal WT, Shah A, Bals S, Sosabowski J and Pankhurst QA (2016). Magnetic Drug Targeting: Preclinical in Vivo Studies, Mathematical Modeling, and Extrapolation to Humans. American Chemical Society  Nano Letters: a journal dedicated to nanoscience and nanotechnology   

Paillas S, Ladjohounlou R, Lozza C, Pichard A, Boudousq V, Jarlier M, Sevestre S, Le Blay M, Deshayes E, Sosabowski J, Chardès T, Navarro-Teulon I, Mairs RJ and Pouget J-P (2016). Localized Irradiation of Cell Membrane by Auger Electrons Is Cytotoxic Through Oxidative Stress-Mediated Nontargeted Effects. Mary Ann Liebert  Antioxidants and Redox Signaling  vol. 25, (8)  

Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Vadivelu KC, Yip PK, Sosabowski J, Trigg W and Michael-Titus AT (2016). In vivo PET imaging of the neuroinflammatory response in rat spinal cord injury using the TSPO tracer [18F]GE-180 and effect of docosahexaenoic acid. European Journal of Nuclear Medicine and Molecular Imaging   

Cabana L, Bourgognon M, Wang JT-W, Protti A, Klippstein R, de Rosales RTM, Shah AM, Fontcuberta J, Tobías-Rossell E, Sosabowski JK, Al-Jamal KT and Tobias G (2016). The Shortening of MWNT-SPION Hybrids by Steam Treatment Improves Their Magnetic Resonance Imaging Properties In Vitro and In Vivo. Wiley: 12 months  Small  vol. 12, (21) 2893-2905.  

Kafa H, Wang JT-W, Rubio N, Klippstein R, Costa PM, Hassan HAFM, Sosabowski JK, Bansal SS, Preston JE, Abbott NJ and Al-Jamal KT (2016). Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood–brain barrier in vitro and in vivo. Elsevier  Journal of Controlled Release  vol. 225, 217-229.  

Bai J, Wang JT-W, Rubio N, Protti A, Heidari H, Elgogary R, Southern P, Al-Jamal WT, Sosabowski J, Shah AM, Bals S, Pankhurst QA and Al-Jamal KT (2016). Triple-Modal Imaging of Magnetically-Targeted Nanocapsules in Solid TumoursIn Vivo. Ivyspring International Publisher  Theranostics  vol. 6, (3) 342-356.  

Wang JT-W, Rubio N, Kafa H, Venturelli E, Fabbro C, Ménard-Moyon C, Da Ros T, Sosabowski JK, Lawson AD, Robinson MK, Prato M, Bianco A, Festy F, Preston JE, Kostarelos K and Al-Jamal KT (2015). Kinetics of functionalised carbon nanotube distribution in mouse brain after systemic injection: Spatial to ultra-structural analyses. Elsevier  Journal of Controlled Release  vol. 224, 22-32.  

Tremoleda JL, Thau-Zuchman O, Davies M, Foster J, Khan I, Trigg W, Sosabowski J, Mather SJ and Michael-Titus A (2015). T-14: IN VIVO IMAGING OF NEUROINFLAMMATION IN NEUROTRAUMA PRECLINICAL MODELS: POTENTIAL FOR CLINICAL TRANSLATION. Shock  vol. 44 Suppl 2, 24-25.  

Staff TPO (2015). Correction: Pharmacokinetic Characteristics, Pharmacodynamic Effect and In Vivo Antiviral Efficacy of Liver-Targeted Interferon Alpha. Public Library of Science (PLoS)  PLOS ONE  vol. 10, (4)  

Tremoleda JL and Sosabowski J (2015). Imaging technologies and basic considerations for welfare of laboratory rodents. Springer Nature  Lab Animal  vol. 44, (3) 97-105.  

Rycroft D, Sosabowski J, Coulstock E, Davies M, Morrey J, Friel S, Kelly F, Hamatake R, Ovečka M, Prince R, Goodall L, Sepp A and Walker A (2015). Pharmacokinetic Characteristics, Pharmacodynamic Effect and In Vivo Antiviral Efficacy of Liver-Targeted Interferon Alpha. Public Library of Science (PLoS)  PLOS ONE  vol. 10, (2)  

Goldstein R, Sosabowski J, Livanos M, Leyton J, Vigor K, Bhavsar G, Nagy-Davidescu G, Rashid M, Miranda E, Yeung J, Tolner B, Plückthun A, Mather S, Meyer T and Chester K (2015). Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging. Eur J Nucl Med Mol Imaging  vol. 42, (2) 288-301.  

Tremoleda JL and Sosabowski J (2015). Imaging technologies and basic considerations for welfare of laboratory rodents. LAB ANIMAL  vol. 44, (3) 101-109.  

Parente-Pereira AC, Shmeeda H, Whilding LM, Zambirinis CP, Foster J, van der Stegen SJC, Beatson R, Zabinski T, Brewig N, Sosabowski JK, Mather S, Ghaem-Maghami S, Gabizon A and Maher J (2014). Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid. J Immunol  vol. 193, (11) 5557-5566.  

Pujatti PB, Foster JM, Finucane C, Hudson CD, Burnet JC, Pasqualoto KFM, Mengatti J, Mather SJ, de Araújo EB and Sosabowski JK (2014). Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models. Elsevier  Applied Radiation and Isotopes  vol. 96, 91-101.  

Roosenburg S, Laverman P, Joosten L, Cooper MS, Kolenc-Peitl PK, Foster JM, Hudson C, Leyton J, Burnet J, Oyen WJG, Blower PJ, Mather SJ, Boerman OC and Sosabowski JK (2014). PET and SPECT imaging of a radiolabeled minigastrin analogue conjugated with DOTA, NOTA, and NODAGA and labeled with (64)Cu, (68)Ga, and (111)In. Mol Pharm  vol. 11, (11) 3930-3937.  

Wang JT-W, Fabbro C, Venturelli E, Ménard-Moyon C, Chaloin O, Da Ros T, Methven L, Nunes A, Sosabowski JK, Mather SJ, Robinson MK, Amadou J, Prato M, Bianco A, Kostarelos K and Al-Jamal KT (2014). The relationship between the diameter of chemically-functionalized multi-walled carbon nanotubes and their organ biodistribution profiles in vivo. Biomaterials  vol. 35, (35) 9517-9528.  

Wang JTW, Cabana L, Bourgognon M, Kafa H, Protti A, Venner K, Shah AM, Sosabowski JK, Mather SJ, Roig A, Ke X, Van Tendeloo G, De Rosales RTM, Tobias G and Al-Jamal KT (2014). Magnetically decorated multiwalled carbon nanotubes as dual mri and spect contrast agents. Advanced Functional Materials  vol. 24, (13) 1880-1894.  

Allen MD, Luong P, Hudson C, Leyton J, Delage B, Ghazaly E, Cutts R, Yuan M, Syed N, Lo Nigro C, Lattanzio L, Chmielewska-Kassassir M, Tomlinson I, Roylance R, Whitaker HC, Warren AY, Neal D, Frezza C, Beltran L, Jones LJ, Chelala C, Wu B-W, Bomalaski JS, Jackson RC, Lu Y-J, Crook T, Lemoine NR, Mather S, Foster J and Sosabowski J (2014). Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging. Cancer Res  vol. 74, (3) 896-907.  

van der Stegen SJC, Davies DM, Wilkie S, Foster J, Sosabowski JK, Burnet J, Whilding LM, Petrovic RM, Ghaem-Maghami S, Mather S, Jeannon J-P, Parente-Pereira AC and Maher J (2013). Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity? J Immunol  vol. 191, (9) 4589-4598.  

Goldstein R, Sosabowski J, Vigor K, Chester K and Meyer T (2013). Developments in single photon emission computed tomography and PET-based HER2 molecular imaging for breast cancer. Expert Rev Anticancer Ther  vol. 13, (3) 359-373.  

Coulstock E, Sosabowski J, Ovečka M, Prince R, Goodall L, Mudd C, Sepp A, Davies M, Foster J, Burnet J, Dunlevy G and Walker A (2013). Liver-targeting of interferon-alpha with tissue-specific domain antibodies. PLoS One  vol. 8, (2)  

Wang JT-W, Cabana L, Bourgognon M, Kafa H, Protti A, Venner K, Shah AM, Sosabowski JK, Mather SJ, Roig A, Ke X, Van Tendeloo G, de Rosales RTM, Tobias G and Al-Jamal KT (2013). Magnetically Decorated Multiwalled Carbon Nanotubes as Dual MRI and SPECT Contrast Agents. Advanced Functional Materials   

Rangger C, Helbok A, Sosabowski J, Kremser C, Koehler G, Prassl R, Andreae F, Virgolini IJ, von Guggenberg E and Decristoforo C (2013). Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles. Int J Nanomedicine  vol. 8, 4659-4671.  

von Guggenberg E, Rangger C, Sosabowski J, Laverman P, Reubi J-C, Virgolini IJ and Decristoforo C (2012). Preclinical evaluation of radiolabeled DOTA-derivatized cyclic minigastrin analogs for targeting cholecystokinin receptor expressing malignancies. Mol Imaging Biol  vol. 14, (3) 366-375.  

Laverman P, Sosabowski JK, Boerman OC and Oyen WJG (2012). Radiolabelled peptides for oncological diagnosis. Eur J Nucl Med Mol Imaging  vol. 39 Suppl 1, (Suppl 1) S78-S92.  

Rangger C, Helbok A, von Guggenberg E, Sosabowski J, Radolf T, Prassl R, Andreae F, Thurner GC, Haubner R and Decristoforo C (2012). Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles. Int J Nanomedicine  vol. 7, 5889-5900.  

Laverman P, Joosten L, Eek A, Roosenburg S, Peitl PK, Maina T, Mäcke H, Aloj L, von Guggenberg E, Sosabowski JK, de Jong M, Reubi J-C, Oyen WJG and Boerman OC (2011). Comparative biodistribution of 12 ¹¹¹In-labelled gastrin/CCK2 receptor-targeting peptides. Eur J Nucl Med Mol Imaging  vol. 38, (8) 1410-1416.  

Aloj L, Aurilio M, Rinaldi V, D'ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, von Guggenberg E, Joosten L, Sosabowski JK, Breeman WAP, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC and de Jong M (2011). Comparison of the binding and internalization properties of 12 DOTA-coupled and ¹¹¹In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607. Eur J Nucl Med Mol Imaging  vol. 38, (8) 1417-1425.  

Ocak M, Helbok A, Rangger C, Peitl PK, Nock BA, Morelli G, Eek A, Sosabowski JK, Breeman WAP, Reubi JC and Decristoforo C (2011). Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607. Eur J Nucl Med Mol Imaging  vol. 38, (8) 1426-1435.  

Finucane CM, Murray I, Sosabowski JK, Foster JM and Mather SJ (2011). Quantitative Accuracy of Low-Count SPECT Imaging in Phantom and In Vivo Mouse Studies. Int J Mol Imaging  vol. 2011,  

Naqvi SAR, Sosabowski JK, Nagra SA, Ishfaq MM, Mather SJ and Matzow T (2011). Radiopeptide internalisation and externalization assays: cell viability and radioligand integrity. Appl Radiat Isot  vol. 69, (1) 68-74.  

Naqvi SAR, Matzow T, Finucane C, Nagra SA, Ishfaq MM, Mather SJ and Sosabowski J (2010). Insertion of a lysosomal enzyme cleavage site into the sequence of a radiolabeled neuropeptide influences cell trafficking in vitro and in vivo. Cancer Biother Radiopharm  vol. 25, (1) 89-95.  

Sosabowski JK, Matzow T, Foster JM, Finucane C, Ellison D, Watson SA and Mather SJ (2009). Targeting of CCK-2 receptor-expressing tumors using a radiolabeled divalent gastrin peptide. J Nucl Med  vol. 50, (12) 2082-2089.  

Sosabowski J, Matzow T, Foster J and Mather S (2009). TARGETING OF CCK2 RECEPTOR EXPRESSING TUMOURS USING AN 111IN-LABELLED MINIGASTRIN DIMER. J LABELLED COMPD RAD  vol. 52, S327-S327.  

Sosabowski JK, Lee M, Dekker BA, Simmons BP, Singh S, Beresford H, Hagan SA, McKenzie AJ, Mather SJ and Watson SA (2007). Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study. Eur J Pharm Sci  vol. 31, (2) 102-111.  

Mather SJ, McKenzie AJ, Sosabowski JK, Morris TM, Ellison D and Watson SA (2007). Selection of radiolabeled gastrin analogs for peptide receptor-targeted radionuclide therapy. J Nucl Med  vol. 48, (4) 615-622.  

Sosabowski JK and Mather SJ (2006). Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes. Nat Protoc  vol. 1, (2) 972-976.  

Sosabowski J and Mather SJ (2005). Radiopharmacy - Overcoming the training barriers. Hospital Pharmacist  vol. 12, (8) 311-313.  

Whelan AN, Elaridi J, Smith SV, Mulder RJ, Robinson AJ and Sosabowski J (2005). SYNTHESIS OF DICARBA ANALOGUES OF OCTREOTIDE USING TANDEM HOMOGENEOUS CATALYSIS. J LABELLED COMPD RAD  vol. 48, S238-S238.  

Sosabowski J, Melendez-Alafort L and Mather S (2003). Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases. Q J NUCL MED  vol. 47, (4) 223-237.  

Fowkes RC, Sidhu KK, Sosabowski JK, King P and Burrin JM (2003). Absence of pituitary adenylate cyclase-activating polypeptide-stimulated transcription of the human glycoprotein alpha-subunit gene in LbetaT2 gonadotrophs reveals disrupted cAMP-mediated gene transcription. J Mol Endocrinol  vol. 31, (2) 263-278.  

Decristoforo C, Melendez-Alafort L, Sosabowski JK and Mather SJ (2000). 99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide. Journal of Nuclear Medicine  vol. 41, (6) 1114-1119.  

Lewis JS, Dearling JLJ, Sosabowski JK, Zweit J, Carnochan P, Kelland LR, Coley HM and Blower PJ (2000). Copper bis(diphosphine) complexes: radiopharmaceuticals for the detection of multi-drug resistance in tumours by PET. Springer Nature  European Journal of Nuclear Medicine and Molecular Imaging  vol. 27, (6) 638-646.  

Brooks RC, Carnochan P, Vollano JF, Powell NA, Zweit J, Sosabowski JK, Martellucci S, Darkes MC, Fricker SP and Murrer BA (1999). Metal complexes of bleomycin: evaluation of [Rh-105]-bleomycin for use in targeted radiotherapy. Elsevier  Nuclear Medicine and Biology  vol. 26, (4) 421-430.